Seeing Is Believing
Healthcare - Sector
LGND is currently covered by 9 analysts with an average price target of $309.31. This is a potential upside of $7.5 (2.49%) from yesterday's end of day stock price of $301.81.
Ligand Pharmaceuticals's activity chart (see below) currently has 230 price targets and 180 ratings on display. The stock rating distribution of LGND is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 92.76% with an average time for these price targets to be met of 365.71 days.
Highest price target for LGND is $397, Lowest price target is $220, average price target is $309.31.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 24-Sep-2026. First documented stock forecast 12-Feb-2014.
Currently out of the existing stock ratings of LGND, 30 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 12-Feb-2014
$358
$56.19 (18.62%)
$358
18 days ago
(24-Sep-2026)
58/60 (96.67%)
$58.96 (19.72%)
683
Buy Since 24-Mar-2026
$397
$95.19 (31.54%)
$387
19 days ago
(23-Sep-2026)
2/4 (50%)
$98.59 (33.04%)
81
Buy Since 30-Jul-2024
$345
$43.19 (14.31%)
$340
2 months 5 days ago
(07-Aug-2026)
11/13 (84.62%)
$51.85 (17.69%)
211
Buy Since 03-Oct-2024
$326
$24.19 (8.01%)
$147
2 months 9 days ago
(03-Aug-2026)
2/3 (66.67%)
$33.96 (11.63%)
280
Buy Since 11-Mar-2026
$388
$86.19 (28.56%)
$260
3 months 3 days ago
(09-Jul-2026)
3/4 (75%)
$65.39 (20.27%)
67
What is LGND (Ligand Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on LGND (Ligand Pharmaceuticals)?
Which analyst has the most public recommendations on LGND (Ligand Pharmaceuticals)?
Which analyst is the currently most bullish on LGND (Ligand Pharmaceuticals)?
Which analyst is the currently most reserved on LGND (Ligand Pharmaceuticals)?